business

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Yahoo Finance · Jun 25, 2026, 12:40 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

MacRumors Apple Just Raised the Price of the MacBook Neo Investing.com Raspberry Pi stock surges after Jefferies raises price target Investing.com JPMorgan raises Micron stock price target to $1,540 on contracts Investing.com RBC Capital initiates VICI Properties stock with $29 price target

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Also covered by

More in business